Pharm prime vendor fleet
Ended Awarded
- Contract number
- SPE2DU26F0C75
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,231
Award facts
- Contract value 100% obligated
- $16,231.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a delivery order valued at $16,231.47 from the Defense Logistics Agency on November 9, 2025. This firm fixed-price delivery order, designated as Contract 4569981582, represents a specific purchase under the company's broader Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order calls for pharmaceutical products and medical consumables to be delivered to Park Ridge, Illinois, with an ultimate completion date of November 10, 2025.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. The PPV-G GEN V contract positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply comprehensive pharmaceutical inventories—including branded and generic prescription medications, biologics, vaccines, and medical consumables—to support Department of Defense military healthcare facilities worldwide. The company's established performance across multiple delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26F0C75?
SPE2DU26F0C75 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 9, 2025.
How much is contract SPE2DU26F0C75 worth?
The government has obligated $16,231 on SPE2DU26F0C75.
Is contract SPE2DU26F0C75 an order under another contract?
Yes. SPE2DU26F0C75 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0C75 competed?
The extent of competition for SPE2DU26F0C75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award